Trastuzumab duocarmazine

Cat. No.: IBDI-432129

Trastuzumab duocarmazine ((vic)-Trastuzumab duocarmazine) is a HER2-targeting ADC that is recognized and cleaved by histone B in tumor cells and selectively targets tumor cells. Trastuzumab duocarmazine has anti-tumor activity and can be used in cancer research related to uterine and ovarian sarcomas.

Product Details

Target	Antibody-Drug Conjugates (ADCs)
Synonyms	(vic)-Trastuzumab duocarmazine
SMILES	[Trastuzumab duocarmazine]

Storage & Handling

Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.